Recombinant human erythropoietin activates a broad spectrum of progenitor cells.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Kidney International

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/KI.1990.21PMID 2299802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo hematopoietic effects of tumor necrosis factor-alpha in normal and erythroleukemic mice: characterization and therapeutic applications.

  1988cited by this paper
• Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.

  1988cited by this paper
• In vivo hematopoietic effects of tumor necrosis factor-alpha in normal and erythroleukemic mice: characterization and therapeutic applications

  1988cited by this paper
• Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo.

  1988cited by this paper
• Fractionation of subsets of BFU-E from normal human bone marrow: responsiveness to erythropoietin, human placental-conditioned medium, or granulocyte-macrophage colony-stimulating factor.

  1988cited by this paper
• In vitro and in vivo effects of recombinant human erythropoietin on human hemopoietic progenitor cells.

  1988cited by this paper
• Effect of human recombinant erythropoietin on human marrow megakaryocyte colony formation in vitro

  1987cited by this paper
• Human recombinant erythropoietin promotes differentiation of murine megakaryocytes in vitro.

  1987cited by this paper
• Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.

  1987cited by this paper
• Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

  1987influential reference
• [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration].

  1987cited by this paper
• Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.

  1987cited by this paper
• Phase I study of recombinant tumor necrosis factor in cancer patients.

  1987cited by this paper
• Effects of recombinant human tumor necrosis factor (rhTNF) on normal human and mouse hemopoietic progenitor cells.

  1987cited by this paper
• Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells.

  1987cited by this paper
• Recombinant human erythropoietin in anaemic patients on haemodialysis.

  1987cited by this paper
• Transfusion and long-term hemodialysis.

  1987cited by this paper
• Recombinant human erythropoietin therapy in haemodialysis patients--dose determination and clinical experience.

  1987cited by this paper
• Effects of recombinant human tumor necrosis factor α, recombinant human γ-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin α, and recombinant erythropoietin in serum-free cultur

  1986cited by this paper
• INCREASED RATIO OF GRANULOCYTE/MACROPHAGE PROGENITOR CELLS (CFU‐GM) TO MULTILINEAGE PROGENITOR CELLS (CFU‐mix) IN THE PERIPHERAL BLOOD FROM PATIENTS WITH ACUTE NON‐LYMPHOBLASTIC LEUKAEMIA IN VERY EARLY REMISSION

  1986cited by this paper
• The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.

  1986cited by this paper
• Erythropoietin treatment in anaemic patients on haemodialysis.

  1986cited by this paper
• The mechanism of action of erythropoietin.

  1986cited by this paper
• Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin.

  1986cited by this paper
• Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.

  1986cited by this paper
• Characterization and biological effects of recombinant human erythropoietin.

  1986cited by this paper
• Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum

  1986cited by this paper
• Control of globin gene transcription by erythropoietin in erythroblasts from friend virus-infected mice

  1985cited by this paper
• Cloning and expression of the human erythropoietin gene.

  1985cited by this paper
• Isolation and characterization of genomic and cDNA clones of human erythropoietin

  1985cited by this paper
• Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes.

  1985cited by this paper
• Erythropoietin stimulates 45Ca2+ uptake in Friend virus-infected erythroid cells.

  1984cited by this paper
• Effect of pure erythropoietin on DNA‐synthesis by human marrow day 15 erythroid burst forming units in short‐term liquid culture

  1984cited by this paper
• The growth of large megakaryocyte colonies from human bone marrow

  1982cited by this paper
• Fluctuations of BFUe and CFUe cycling after erytrhoid perturbations: correlation with variations of pool size.

  1980cited by this paper
• Cellular interactions in haematopoiesis

  1979cited by this paper
• Erythropoietin levels in uremic nephric and anephric patients.

  1979cited by this paper
• Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood.

  1978cited by this paper
• Analysis of erythropoiesis by erythroid colony formation in culture.

  1978cited by this paper
• Erythropoietin and the control of red cell production.

  1978cited by this paper
• Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood

  1978cited by this paper
• Erythropoietic precursors in mice under erythropoietic stimulation and suppression.

  1977cited by this paper
• Disorders of red blood cell production in uremia.

  1970cited by this paper
• On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other

  1947cited by this paper

• Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.

  2023cites this paper
• Acute Leukemia and Erythropoietin Cause or Casual

  2015cites this paper
• Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients.

  2014cites this paper
• Epoetin

  2012cites this paper
• Anemia of Critical Illness

  2008cites this paper
• Impact of anemia and red blood cell transfusion on organ function

  2008cites this paper
• Alternatives to blood product transfusion in the critically ill: Erythropoietin

  2006cites this paper
• Circulating haematopoietic progenitors during treatment of renal anaemia with recombinant human erythropoietin

  2005cites this paper
• Current status and future developments of rhEPO in clinical oncology

  2002cites this paper
• Impact of anemia on organ functions

  2002cites this paper
• Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology

  2002cites this paper
• Stimulation of Tumour Necrosis Factor-alpha Production by Recombinant Human Erythropoietin may Contribute to Failure of Therapy

  2000cites this paper
• [The effect of erythropoietin (rh-EPO) om in vitro proliferation of granulocyte/monocyte-determined stem cells in bone marrow and peripheral blood].

  1999cites this paper
• Interaction between Erythropoietin and Peripheral Polymorphonuclear Leukocytes in Hemodialysis Patients

  1999cites this paper
• Der Einfluß einer rh-EPO-Therapie auf die In-vitro-Proliferation granulozytär-monozytär determinierter Stammzellen aus Knochenmark und peripherem Blut

  1999cites this paper
• The acute effect of intravenously administered recombinant human erythropoietin on the immune response of uremic patients maintained on regular hemodialysis.

  1998cites this paper
• The impact of early normalization of haematocrit by erythropoietin on renal damage in the remnant kidney model.

  1998cites this paper
• High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome.

  1998cites this paper
• Fetal proteins and chronic treatment with low-dose erythropoietin.

  1997cites this paper
• The Effect of Recombinant Human Erythropoietin on Circulating Hematopoietic Progenitor Cells in Anemic Premature Infants

  1997cites this paper
• Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer.

  1997cites this paper
• Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial.

  1996cites this paper
• Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patients.

  1996cites this paper
• Stimulation of Interleukin-1 ß Production may be Involved in Unresponsiveness to Erythropoietin Therapy

  1996cites this paper
• Recombinant human reduces the need for platelet transfusions in erythropoietin erythrocyte and pediatric patients with sarcoma: A randomized, double-blind, placebo-controlled trial

  1996cites this paper
• The effect of erythropoietin administration on murine bone marrow chimeras.

  1996cites this paper
• Intrarenal extramedullary erythropoiesis in renal allograft fine-needle aspirates.

  1995cites this paper
• Bone marrow findings before and after treatment with recombinant human erythropoietin in chronic hemodialyzed patients.

  1995cites this paper
• ANEMIA AND ERYTHROPOIETIN LEVELS IN LUNG TRANSPLANT RECIPIENTS

  1995cites this paper
• Acute leukemia and erythropoietin: cause or casual relationship?

  1995cites this paper
• Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.

  1995cites this paper
• Impaired erythropoietin responsiveness in anaemic rheumatoid arthritis patients: potential relation to immune mechanisms.

  1994cites this paper
• Effect of recombinant erythropoietin therapy on autoimmunity in systemic lupus erythematosus.

  1994cites this paper
• Recombinant human erythropoietin increases interleukin-1 beta production in cultured peripheral blood mononuclear cells from patients resistant to recombinant human erythropoietin therapy.

  1994cites this paper
• Recombinant human erythropoietin and the anemia of cancer.

  1994cites this paper
• Erythropoietin: mechanisms of action and indications for treatment.

  1993cites this paper
• Long-term effects of recombinant human erythropoietin on bone marrow progenitor cells.

  1993cites this paper
• Preoperative evaluation for diabetic renal transplantation: impact of clinical, laboratory, and echocardiographic parameters on patient and allograft survival.

  1992cites this paper
• Erythropoietin: structure, control of production, and function.

  1992cites this paper
• Effects of recombinant human erythropoietin (rhEPO) on myelo-and thrombopoiesis of rabbits

  1992cites this paper
• Epoetin enhances erythropoiesis in normal men undergoing repeated phlebotomies

  1992cites this paper
• Erythropoietin treatment in allogeneic BMT accelerates erythroid reconstitution: results of a prospective controlled randomized trial.

  1992cites this paper
• Stimulating erythropoiesis increases complement receptor expression on primate erythrocytes.

  1992cites this paper
• In Vivo Effects of Recombinant Human Erythropoietin on Circulating CD34+ Cells of Uremic Patients

  1992cites this paper
• [Megakaryocytes in the blood of a patient treated with erythropoietin].

  1991cites this paper
• LEUKOCYTOSIS IN HEMOLYTIC‐UREMIC SYNDROME

  1991cites this paper
• Erythropoietin: a hormone finds a purpose.

  1991cites this paper
• Effect of estrogens and progesterone on human peripheral erythroid burst‐forming unit (BFU‐E) growth

  1991cites this paper
• Erythropoietin: evolving clinical applications.

  1991cites this paper
• Weekly subcutaneous recombinant human erythropoietin corrects anemia of progressive renal failure.

  1991cites this paper
• Pharmacokinetics and dose response after intravenous and subcutaneous administration of recombinant erythropoietin in patients on regular haemodialysis treatment or continuous ambulatory peritoneal dialysis.

  1991cites this paper
• Bone marrow changes following treatment of renal anemia with erythropoietin.

  1991cites this paper